ID
12802
Description
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00991744
Link
https://clinicaltrials.gov/show/NCT00991744
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT00991744
Eligibility Acute Lymphoblastic Leukemia NCT00991744
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
persistent nci grade 3-4 neurotoxicity
Data type
boolean
Alias
- UMLS CUI [1]
- C0235032
Description
bilineage all
Data type
boolean
Alias
- UMLS CUI [1]
- C0023464
Description
leukemia predisposing syndromes
Data type
boolean
Alias
- UMLS CUI [1]
- C0314657
- UMLS CUI [2]
- C0013080
- UMLS CUI [3]
- C0004135
Description
previous cancer
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0521987
- UMLS CUI [1,2]
- C0006826
Description
intolerance
Data type
boolean
Alias
- UMLS CUI [1]
- C1744706
Description
contraceptive methods
Data type
boolean
Alias
- UMLS CUI [1]
- C0700589
Description
intrathecal liposomal cytarabine
Data type
boolean
Alias
- UMLS CUI [1]
- C1455694
- UMLS CUI [2]
- C0677897
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00991744
- StudyEvent: Eligibility
C0023449 (UMLS CUI [2])
C1555471 (UMLS CUI [2])
C0013080 (UMLS CUI [2])
C0004135 (UMLS CUI [3])
C0006826 (UMLS CUI [1,2])
C0677897 (UMLS CUI [2])